An Act relative to cancer patient access to biomarker testing to provide appropriate therapy
Filed by Meghan K. Kilcoyne · 77 cosponsors · 193rd General Court · the legislature's own page
H1074 · Bill · docket HD2413
10 actions
In the order the legislature recorded them.
| Date | Branch | Action |
|---|
| 2023-02-16 | House | Referred to the committee on Financial Services |
| 2023-02-16 | Senate | Senate concurred |
| 2023-04-18 | Joint | Hearing scheduled for 05/02/2023 from 10:00 AM-01:00 PM in A2 and virtual |
| 2023-04-28 | Joint | Hearing rescheduled to 05/02/2023 from 10:00 AM-01:00 PM in Gardner Auditorium |
| 2024-02-08 | House | Reporting date extended to Friday May 17, 2024, pending concurrence |
| 2024-03-28 | Senate | Senate concurred |
| 2024-05-23 | House | Reported favorably by committee and referred to the committee on Health Care Financing |
| 2024-06-20 | House | Accompanied by S689 |
| 2024-06-20 | House | Committee recommended bill ought to pass and referred to the committee on House Ways and Means |
| 2024-12-31 | House | No further action taken |
1 of these was struck from the record by the clerk and shown ruled through, because a struck line is part of what the record says happened.
Public hearing
House Rule 27 counts its reporting deadline from the day a bill is heard.
Committee actions
Cosponsors
In the order filed.
Every action here is as the legislature published it. A bill that drew no recorded vote is the ordinary case: the House records roughly 150 a year.